Cigarette smoking and the risk of endometrial cancer

Fabio Levi, Carlo la Vecchia, Adriano Decarli

Research output: Contribution to journalArticle

Abstract

The risk of endometrial cancer in relation to cigarette consumption was evaluated in a hospital-based case-control study of breast and genital neoplasms conducted in Milan, northern Italy. For the present analysis, 357 women (cases) with histologically confirmed endometrial cancer were compared to a group of 1122 women (controls) admitted for a large spectrum of acute conditions unrelated to smoking or to any of the known or potential risk factors for endometrial cancer. Compared with never-smokers, the multivariate relative risk estimates were for current 0.45 [95% confidence interval (CI) = 0.30-0.70] and 0.86 (95% CI = 0.50-1.46) for ex-smokers. The negative association of endometrial cancer with current smoking was not influenced by menopausal status as well as by other major identified potential confounding factors, i.e. menstrual and reproductive history, body mass index, oral contraceptive or estrogen replacement therapy use and family gynecologic cancer history. However, there was no evidence of a dose-risk effect, since the relative risks were similar in moderate and heavy smokers. The present study confirms that smoking is less frequent in cases hospitalized for endometrial cancer than in a comparison group of patients with non-smoking-related acute conditions. This negative association is perhaps explained in terms of reduced estrogen levels in smokers, though the influence and the importance of some uncontrolled selection bias (due, for instance, to longer hospital stay of smokers even when admission diagnosis was for non-smoking-related conditions) cannot be ruled out.

Original languageEnglish
Pages (from-to)1025-1029
Number of pages5
JournalEuropean Journal of Cancer and Clinical Oncology
Volume23
Issue number7
DOIs
Publication statusPublished - 1987

Fingerprint

Endometrial Neoplasms
Smoking
Confidence Intervals
Reproductive History
Estrogen Replacement Therapy
Selection Bias
Oral Contraceptives
Tobacco Products
Italy
Case-Control Studies
Length of Stay
Estrogens
Body Mass Index
Breast Neoplasms
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Cigarette smoking and the risk of endometrial cancer. / Levi, Fabio; la Vecchia, Carlo; Decarli, Adriano.

In: European Journal of Cancer and Clinical Oncology, Vol. 23, No. 7, 1987, p. 1025-1029.

Research output: Contribution to journalArticle

Levi, Fabio ; la Vecchia, Carlo ; Decarli, Adriano. / Cigarette smoking and the risk of endometrial cancer. In: European Journal of Cancer and Clinical Oncology. 1987 ; Vol. 23, No. 7. pp. 1025-1029.
@article{9faf181e0ac24890a40fa14e50c56cbc,
title = "Cigarette smoking and the risk of endometrial cancer",
abstract = "The risk of endometrial cancer in relation to cigarette consumption was evaluated in a hospital-based case-control study of breast and genital neoplasms conducted in Milan, northern Italy. For the present analysis, 357 women (cases) with histologically confirmed endometrial cancer were compared to a group of 1122 women (controls) admitted for a large spectrum of acute conditions unrelated to smoking or to any of the known or potential risk factors for endometrial cancer. Compared with never-smokers, the multivariate relative risk estimates were for current 0.45 [95{\%} confidence interval (CI) = 0.30-0.70] and 0.86 (95{\%} CI = 0.50-1.46) for ex-smokers. The negative association of endometrial cancer with current smoking was not influenced by menopausal status as well as by other major identified potential confounding factors, i.e. menstrual and reproductive history, body mass index, oral contraceptive or estrogen replacement therapy use and family gynecologic cancer history. However, there was no evidence of a dose-risk effect, since the relative risks were similar in moderate and heavy smokers. The present study confirms that smoking is less frequent in cases hospitalized for endometrial cancer than in a comparison group of patients with non-smoking-related acute conditions. This negative association is perhaps explained in terms of reduced estrogen levels in smokers, though the influence and the importance of some uncontrolled selection bias (due, for instance, to longer hospital stay of smokers even when admission diagnosis was for non-smoking-related conditions) cannot be ruled out.",
author = "Fabio Levi and {la Vecchia}, Carlo and Adriano Decarli",
year = "1987",
doi = "10.1016/0277-5379(87)90353-1",
language = "English",
volume = "23",
pages = "1025--1029",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "7",

}

TY - JOUR

T1 - Cigarette smoking and the risk of endometrial cancer

AU - Levi, Fabio

AU - la Vecchia, Carlo

AU - Decarli, Adriano

PY - 1987

Y1 - 1987

N2 - The risk of endometrial cancer in relation to cigarette consumption was evaluated in a hospital-based case-control study of breast and genital neoplasms conducted in Milan, northern Italy. For the present analysis, 357 women (cases) with histologically confirmed endometrial cancer were compared to a group of 1122 women (controls) admitted for a large spectrum of acute conditions unrelated to smoking or to any of the known or potential risk factors for endometrial cancer. Compared with never-smokers, the multivariate relative risk estimates were for current 0.45 [95% confidence interval (CI) = 0.30-0.70] and 0.86 (95% CI = 0.50-1.46) for ex-smokers. The negative association of endometrial cancer with current smoking was not influenced by menopausal status as well as by other major identified potential confounding factors, i.e. menstrual and reproductive history, body mass index, oral contraceptive or estrogen replacement therapy use and family gynecologic cancer history. However, there was no evidence of a dose-risk effect, since the relative risks were similar in moderate and heavy smokers. The present study confirms that smoking is less frequent in cases hospitalized for endometrial cancer than in a comparison group of patients with non-smoking-related acute conditions. This negative association is perhaps explained in terms of reduced estrogen levels in smokers, though the influence and the importance of some uncontrolled selection bias (due, for instance, to longer hospital stay of smokers even when admission diagnosis was for non-smoking-related conditions) cannot be ruled out.

AB - The risk of endometrial cancer in relation to cigarette consumption was evaluated in a hospital-based case-control study of breast and genital neoplasms conducted in Milan, northern Italy. For the present analysis, 357 women (cases) with histologically confirmed endometrial cancer were compared to a group of 1122 women (controls) admitted for a large spectrum of acute conditions unrelated to smoking or to any of the known or potential risk factors for endometrial cancer. Compared with never-smokers, the multivariate relative risk estimates were for current 0.45 [95% confidence interval (CI) = 0.30-0.70] and 0.86 (95% CI = 0.50-1.46) for ex-smokers. The negative association of endometrial cancer with current smoking was not influenced by menopausal status as well as by other major identified potential confounding factors, i.e. menstrual and reproductive history, body mass index, oral contraceptive or estrogen replacement therapy use and family gynecologic cancer history. However, there was no evidence of a dose-risk effect, since the relative risks were similar in moderate and heavy smokers. The present study confirms that smoking is less frequent in cases hospitalized for endometrial cancer than in a comparison group of patients with non-smoking-related acute conditions. This negative association is perhaps explained in terms of reduced estrogen levels in smokers, though the influence and the importance of some uncontrolled selection bias (due, for instance, to longer hospital stay of smokers even when admission diagnosis was for non-smoking-related conditions) cannot be ruled out.

UR - http://www.scopus.com/inward/record.url?scp=0023235071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023235071&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(87)90353-1

DO - 10.1016/0277-5379(87)90353-1

M3 - Article

C2 - 3665988

AN - SCOPUS:0023235071

VL - 23

SP - 1025

EP - 1029

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 7

ER -